| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |